Takahashi, M., Takahashi, S., Mori, A., Hatachi, S., Saito, T., Shinohara, M., & Kumagai, S. (2026). Early Erythrocyte Methotrexate Polyglutamate-4 Predicts Treatment Response and Is Influenced by GGH 401C>T Genotype in Patients with Rheumatoid Arthritis. Archives of Rheumatology, 41(2), 125. https://doi.org/10.5152/ArchRheumatol.2026.25173
Chicago Style (17th ed.) CitationTakahashi, Miho, Soshi Takahashi, Ayano Mori, Saori Hatachi, Toshiharu Saito, Masakazu Shinohara, and Shunichi Kumagai. "Early Erythrocyte Methotrexate Polyglutamate-4 Predicts Treatment Response and Is Influenced by GGH 401C>T Genotype in Patients with Rheumatoid Arthritis." Archives of Rheumatology 41, no. 2 (2026): 125. https://doi.org/10.5152/ArchRheumatol.2026.25173.
MLA (9th ed.) CitationTakahashi, Miho, et al. "Early Erythrocyte Methotrexate Polyglutamate-4 Predicts Treatment Response and Is Influenced by GGH 401C>T Genotype in Patients with Rheumatoid Arthritis." Archives of Rheumatology, vol. 41, no. 2, 2026, p. 125, https://doi.org/10.5152/ArchRheumatol.2026.25173.